ICDs accounted for the largest share of the defibrillators market in 2019

The global defibrillators market is projected to reach USD 11.7 billion by 2025 from USD 9.6 billion in 2019, at a CAGR of 3.4 percent, estimates MarketsandMarkets. The growth in this market is driven by the rising prevalence of target diseases, growing focus on providing public-access defibrillators, and training and awareness programs on defibrillators. In addition, emerging markets and the development of S-ICDs and MRI-compatible ICDs and
CRT-Ds are expected to offer growth opportunities for players in the market. The ICDs segment accounted for the largest share of the defibrillators market in 2019. Factors such as the development of technologically advanced devices with extended longevity, rapid growth in the number of implant procedures, and increasing adoption of cardiac resynchronization therapy defibrillators (CRT-Ds) and S-ICD systems across the globe are contributing to the large share of this segment.
In 2019, North America accounted for the largest share of the market. The rising geriatric population, increasing incidence of cardiac diseases, and technological advancements are the major factors driving the growth of the market in North America. Prominent players in the market include Medtronic, St. Jude Medical, Boston Scientific, Philips, Zoll Medical, Biotronik, Physio-Control, Nihon Kohden, Schiller AG, Mindray Medical, Mediana, and METsis Medikal.